For the Inventor, By the Inventor

Enter assignee name

Plymouth, MN, United States of America

Nuvaira, Inc.

USPTO Granted Patents = 25

% Expired Patents = 4.0

CIPO Patents = 3

EPO Patents = 12

Trademarks = 4

Forward Citations = 120

Loading Chart...

Loading Chart...

19 inventors (with patents filed for the assignee):

Martin L Mayse (20 out of 59 patents)

Steven Charles Dimmer (10 out of 72 patents)

Mark E Deem (6 out of 146 patents)

4. Hanson S Gifford, Iii (4 out of 265 patents)

5. Steven Paul Mertens (4 out of 27 patents)

6. John Streeter (3 out of 22 patents)

7. Edwin J Hlavka (3 out of 84 patents)

8. Ryan Kaveckis (3 out of 5 patents)

9. Lynn H Elliott (3 out of 34 patents)

10. Richard Charles Gunderson (2 out of 52 patents)

11. Larry Wales (2 out of 25 patents)

12. Edward Scott Harshman (2 out of 9 patents)

13. Matt Heidner (1 out of 24 patents)

14. Scott Harshman (1 out of 7 patents)

15. Kyle True (1 out of 1 patent)

25 patents: Sort by Forward Citations

1. 12721677 - Apparatuses and methods for injuring nerve tissue (2026-09-01),

2. 12357827 - System and method for bronchial dilation (2025-07-15),

3. 12343060 - Non-invasive and minimally invasive denervation methods and systems for performing the same (2025-07-01),

4. 12290309 - Systems, apparatuses, and methods for treating tissue and controlling stenosis (2025-05-06),

5. 12114916 - Catheter and handle assembly, systems, and methods (2024-10-15),

6. 11937868 - Systems, assemblies, and methods for treating a bronchial tree (2024-03-26),

7. 11896294 - Method and systems for reducing treatment variability and increasing treatment efficacy and durability (2024-02-13),

8. 11849994 - Apparatuses and methods for injuring nerve tissue (2023-12-26),

9. 11771492 - Systems and methods for improved delivery of expandable catheter assemblies into body lumens (2023-10-03),

10. 11712283 - Non-invasive and minimally invasive denervation methods and systems for performing the same (2023-08-01),

11. 11446524 - Systems, devices, and methods for treating a pulmonary disease with ultrasound energy (2022-09-20),

12. 11389233 - Systems, apparatuses, and methods for treating tissue and controlling stenosis (2022-07-19),

13. 11103684 - Systems, devices, and methods for treating a pulmonary disorder with an agent (2021-08-31),

14. 11058879 - System and method for bronchial dilation (2021-07-13),

15. 10953170 - Apparatus for treating asthma using neurotoxin (2021-03-23),

Nuvaira, Inc. is a medical technology company dedicated to improving the lives of patients with obstructive lung diseases. The company develops innovative solutions to treat chronic obstructive pulmonary disease (COPD), asthma, and other lung conditions. Nuvaira's goal is to help patients breathe easier and enjoy a better quality of life by providing cutting-edge therapies and devices.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

25 Patents

#24 in Plymouth, MN

#398 in Minnesota

#13,334 in US

#25,651 in the World

Plymouth, MN, United States of America

Nuvaira, Inc.

Forward Citations = 120

19 inventors:

Martin L Mayse (20 out of 59 patents)

Steven Charles Dimmer (10 out of 72 patents)

Mark E Deem (6 out of 146 patents)

4. Hanson S Gifford, Iii (4 out of 265 patents)

5. Steven Paul Mertens (4 out of 27 patents)

Please report any incorrect information to [email protected]

Loading…